Boston Scientific to Highlight Innovations at Upcoming Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) is gearing up for its participation in the prestigious J.P. Morgan Healthcare Conference, a hallmark event in the medical industry calendar. This year, the conference will take place in San Francisco, where top leaders and innovators gather to share insights and developments in healthcare.
Key Participants and Schedule
Attending the event from Boston Scientific will be Mike Mahoney, the company’s chairman and chief executive officer, alongside Jon Monson, executive vice president and chief financial officer, and Dr. Ken Stein, the senior vice president and global chief medical officer. This trio will take to the stage for a comprehensive 40-minute question-and-answer session, set to kick off around 9:00 a.m. PT / 12:00 p.m. ET on January 13, 2026.
Financial Overview and Webcast Details
In conjunction with the conference, Boston Scientific is set to host a conference call on February 4, 2026, at 8:00 a.m. ET to discuss the financial results of its fourth quarter and full year ending December 31, 2025. This call will be led by Mahoney and Monson, providing key insights into the company’s performance over the previous year. Investors and analysts can look forward to a news release detailing Boston Scientific’s financial outcomes, which will precede the conference call.
Implications for Investors and Stakeholders
For investors, these events are more than just formalities; they offer a glimpse into the future direction of Boston Scientific. With its commitment to innovative technologies, the discussions at the J.P. Morgan Healthcare Conference will surely shed light on how the company plans to address market challenges and patient needs effectively.
About Boston Scientific and Its Achievements
Boston Scientific is a global leader in medical technology, boasting over 45 years of experience in improving patient care worldwide through groundbreaking medical solutions. The company focuses on enhancing the lives of patients by addressing various complex health conditions and being at the forefront of technological advancement. With its diverse range of medical devices and therapies, Boston Scientific remains determined to meet the ongoing challenges in healthcare.
Engaging with Boston Scientific
Individuals interested in the company’s initiatives and results can learn more by visiting www.bostonscientific.com. The website not only offers insights into their extensive range of products but also provides opportunities for engagement through social media platforms, including LinkedIn.
Contact Information
For media inquiries, Emily Anderson leads the communication efforts. She can be reached at +1 (617) 515-2000 for any questions related to media coverage. Investors looking for financial information can reach out to Lauren Tengler at +1 (508) 683-4479.
Frequently Asked Questions
What is the J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference is a major event that brings together healthcare and medical companies to discuss financial results and future strategies.
What will Boston Scientific discuss during the conference?
Boston Scientific will highlight its financial results for Q4 and the full year, along with its strategic initiatives and innovations in medical technology.
How can I access the conference call?
The conference call can be accessed live via the Boston Scientific investor relations website on February 4, 2026.
Who are the key speakers from Boston Scientific?
Mike Mahoney, Jon Monson, and Dr. Ken Stein will represent Boston Scientific at the conference.
What is Boston Scientific known for?
Boston Scientific is known for its innovative medical technologies that enhance healthcare quality and patient outcomes globally.
